A Wayne State University research team in the Eugene Applebaum College of Pharmacy and Health Sciences has developed a novel approach to the design of nanocarriers for treatment of metastatic cancer and inflammatory diseases. Published in the international chemistry journal Angewandte Chemie, the study "Dual-function CXCR4 Antagonist Polyplexes to Deliver Gene Therapy and Inhibit Cancer Cell Invasion" introduces a new type of nanocarriers that have unique dual functionality. "The nanocarriers not only limit metastasis and inflammation, but also deliver additional therapeutic agents with anticancer or anti-inflammatory activity," said associate professor David Oupicky, who heads the research team in the college's department of pharmaceutical sciences. The study is supported in part by a research enhancement grant from WSU's Office of the Vice President for Research and a grant from the National Institutes of Biomedical Imaging and Bioengineering of the National Institutes of Health. A photo of the research team is included.

http://detroit.cbslocal.com/2012/09/10/wsu-research-team-eyes-nanocarriers-to-treat-cancer-inflammatory-diseases/
http://mms.tveyes.com/Transcript.asp?StationID=2785&DateTime=9%2F11%2F2012+6%3A12%3A04+AM&LineNumber=&MediaStationID=2785&playclip=True&RefPage=